LS 2

Name: Shanshan Liang PhD.

Fellowship Researcher
Research Assistant in Zhongshan affiliated hospital of Dalian university, China.

Scientific field: Oncology

Papers

  1. Wang Z, Liu G, Mao J, Xie M, Zhao M, Guo X, Liang S, Li H, Li X, Wang R. IGF-1R inhibition suppresses cell proliferation and increases radiosensitivity in nasopharyngeal carcinoma cells. Mediat Inflamm 2019:1-9 (2019). doi: 10.1155/2019/5497467. New!!
  2. Nakazawa S, Sakata KI, Liang S, Yoshikawa K, Iizasa H, Tada M, Hamada JI, Kashiwazaki H, Kitagawa Y, Yamazaki Y. Dominant-negative p53 mutant R248Q increases the motile and invasive activities of oral squamous cell carcinoma cells. Biomed Res 40(1):37-49 (2019). doi: 10.2220/biomedres.40.37. 
  3. Wang R, Li H, Guo X, Wang Z, Liang S, Dang C. IGF-I Induces Epithelial-to-Mesenchymal Transition via the IGF-IR-Src-MicroRNA-30a-E-Cadherin Pathway in Nasopharyngeal Carcinoma Cells. Oncol Res. 24(4):225-231 (2016). doi: 10.3727/096504016X14648701447931.
  4. Li H, Zhao T, Ji X, Liang S, Wang Z, Yang Y, Yin J, Wang R.Hyperfibrinogenemia predicts poor prognosis in patients with advanced biliary tract cancer.Tumour Biol 37(3):3535-3542 (2016). doi: 10.1007/s13277-015-4184-6.
  5. Goudarzi H, Iizasa H, Furuhashi M, Nakazawa S, Nakane R, Liang S, Hida Y, Yanagihara K, Kubo T, Nakagawa K, Kobayashi, M, Irimura T, Hamada J. Enhancement of in vitro cell motility and invasiveness of human malignant pleural mesothelioma cells through the HIF-1α-MUC1 pathway. Cancer Lett 339 (1) : 82-92 (2013).
  6. Liang S, Furuhashi M, Nakane R, Nakazawa S, Goudarzi H, Hamada J, Iizasa H*. Isolation and characterization of human breast cancer cells with SOX2 promoter activity. Biochem Biophys Res Commun 437 (2) : 205-211 (2013).